HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

The Past, Present and Future of the Total Artificial Heart

The Texas Heart Institute

W. Cohn, O. Frazier

High-Risk Cardiac Surgery and Pre-Op Optimization with Impella Base …

St. Louis Shock & Heart Failure Symposium 2022

J. Leidenfrost

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

The Cardiogenic Shock Working Group

N. Kapur

Contemporary Management of Cardiogenic Shock: Updates in 2022

Mount Sinai Advanced Innovations in Heart Failure

D. Baran

Use of MCS in Management of Acute Post-MI VSD

Houston Shock Symposium

D. Ramini

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

American Heart & Vascular Institute

M. Ansari

Cardiac Surgery Case: Post Cardiotomy Shock Requiring Mechanical Cir…

The 10th Annual Western New England Acute Cardiology Conference

K. Wanamaker

Timing and Choice of Percutaneous Mechanical Circulatory Support (pM…

UChicago Medicine

S. Nathan

The Other Option for Hemodynamic Support in High Risk PCI

Joseph Thomas

SCAD Case: How to Manage It

Scottsdale Interventional Forum 2022

D. A. Cox

Cardiogenic Shock: All Mechanical Circulatory Support Devices

Complex Coronary Cases

G. Serrao

Protected PCI for Complete Revascularization

Texas Cardiovascular Innovations Conference 2021

H. Nguyen

Cardiogenic Shock: Treatment Options

NYU Langone

S. Hall

Right Ventricular Failure

Scripps Health

A. Bharadwaj

Identifying Right Ventricular Failure: Labs, Echo or PA Catheter?

Scripps Cardiogenic Shock and Resuscitation Symposium

R. Mohan

Right Ventricular Failure: Diagnosis and Management

Scripps Health: 2019 Third Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension

A. Srivastava